UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.328

Sortiert nach

Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis

JACC. Cardiovascular interventions, 2016-11, Vol.9 (22), p.2267-2276

2016

Volltextzugriff (PDF)

Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries

International journal of cardiology, 2022-08, Vol.361, p.103-108

2022

Volltextzugriff (PDF)

A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes

Journal of the American College of Cardiology, 2010-06, Vol.55 (23), p.2556-2566

2010

Volltextzugriff (PDF)

Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing: Impact of Prasugrel and High-Dose Clopidogrel

Journal of the American College of Cardiology, 2014-03, Vol.63 (11), p.1061-1070

2014

Volltextzugriff (PDF)

Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention

JACC. Cardiovascular interventions, 2023-04, Vol.16 (7), p.829-843

2023

Volltextzugriff (PDF)

Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design

BMC cardiovascular disorders, 2024-01, Vol.24 (1), p.62-62, Article 62

2024

Volltextzugriff (PDF)

Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy

JACC. Cardiovascular interventions, 2010-08, Vol.3 (8), p.806-811

2010

Volltextzugriff (PDF)

Impact of Society Guidelines on Trends in Use of Newer P2Y 12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Journal of the American Heart Association, 2024-05, Vol.13 (9), p.e034414

2024

Volltextzugriff (PDF)

Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48hours

Archives of cardiovascular diseases, 2024-05, Vol.117 (5), p.351-357

2024

Volltextzugriff (PDF)

Efficacy and Safety of Ticagrelor versus Clopidogrel with Different Dosage in High-risk Patients with Acute Coronary Syndrome

International journal of cardiology, 2017-02, Vol.228, p.275-279

2017

Volltextzugriff (PDF)

Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

JACC. Cardiovascular interventions, 2022-05, Vol.15 (9), p.999-1000

2022

Volltextzugriff (PDF)

Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

JACC. Cardiovascular interventions, 2022-05, Vol.15 (9), p.999-999

2022

Volltextzugriff (PDF)

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016-12, Vol.12 (11), p.e1404

2016

Volltextzugriff (PDF)

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

BMC cardiovascular disorders, 2023-01, Vol.23 (1), p.6-6, Article 6

2023

Volltextzugriff (PDF)

Impact of Close Surveillance on Dual-Antiplatelet Therapy Compliance in Myocardial Infarction Patients Post-Percutaneous Coronary Intervention

Cardiovascular revascularization medicine, 2023-03, Vol.48, p.7-14

2023

Volltextzugriff (PDF)

Timing, Selection, Modulation, and Duration of P2Y 12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI

JACC. Cardiovascular interventions, 2023-01, Vol.16 (1), p.1

2023

Volltextzugriff (PDF)

Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)

JACC. Cardiovascular interventions, 2013-12, Vol.6 (12), p.1275-1281

2013

Volltextzugriff (PDF)

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy : Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2008-05, Vol.51 (18), p.1734-1741

2008

Volltextzugriff (PDF)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents

Cardiovascular diabetology, 2021-07, Vol.20 (1), p.137-137, Article 137

2021

Volltextzugriff (PDF)

Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events)

JACC. Cardiovascular interventions, 2009-01, Vol.2 (1), p.26-33

2009

Volltextzugriff (PDF)

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis

JACC. Cardiovascular interventions, 2016-01, Vol.9 (1), p.12-24

2016

Volltextzugriff (PDF)

The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes

JACC. Cardiovascular interventions, 2010-12, Vol.3 (12), p.1209-1219

2010

Volltextzugriff (PDF)

Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes

JACC. Cardiovascular interventions, 2018-08, Vol.11 (15), p.1437-1449

2018

Volltextzugriff (PDF)

Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese Patients With Acute Coronary Syndrome　– Randomized, Double-Blind, Phase III PHILO Study

Circulation Journal, 2015/10/23, Vol.79(11), pp.2452-2460

2015

Volltextzugriff (PDF)

1 – 25 von 2.328

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.167)
Mit Volltextzugriff
(1.936)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.317)
Science & Technology
(1.951)
Life Sciences & Biomedicine
(1.884)
Male
(1.449)
Cardiovascular System & Cardiology
(1.418)
Female
(1.413)
Cardiac & Cardiovascular Systems
(1.347)
Middle Aged
(1.275)
Aged
(1.216)
Acute Coronary Syndrome - Therapy
(885)
Acute Coronary Syndrome
(782)
Acute Coronary Syndromes
(776)
Risk Factors
(755)
Acute Coronary Syndrome - Drug Therapy
(651)
Time Factors
(625)
Percutaneous Coronary Intervention
(501)
Acute Coronary Syndrome - Diagnosis
(478)
Platelet Aggregation Inhibitors - Therapeutic Use
(423)
Heart Attacks
(421)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy

Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries

A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes

Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing: Impact of Prasugrel and High-Dose Clopidogrel

Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention

Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design

Impact of Society Guidelines on Trends in Use of Newer P2Y 12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48hours

Efficacy and Safety of Ticagrelor versus Clopidogrel with Different Dosage in High-risk Patients with Acute Coronary Syndrome

Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

Impact of Close Surveillance on Dual-Antiplatelet Therapy Compliance in Myocardial Infarction Patients Post-Percutaneous Coronary Intervention

Timing, Selection, Modulation, and Duration of P2Y 12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI

Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy : Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents

Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events)

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis

The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes

Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes

Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese Patients With Acute Coronary Syndrome　– Randomized, Double-Blind, Phase III PHILO Study

Aktive Filter

Suchergebnisse filtern